Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: Effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism

Critical Care Medicine

Volumn 33, Issue 2, 2005, Pages 373-380

  Asfar, Pierre ^a,b   Hauser, Balázs ^a,c   Iványi, Zsolt ^a,c   Ehrmann, Ulrich ^a   Kick, Jochen ^a,d   Albicini, Maura ^a,e   Vogt, Josef ^a   Wachter, Ulrich ^a   Brückner, Uwe Bernd ^d   Radermacher, Peter ^a   Bracht, Hendrik ^a  

^a Sekt Anasthesiol Pathophysiol/V   (Germany)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Endogenous glucose production; Hepatic arterial buffer response; Lactate; Microcirculation; Pyruvate; Vasopressin analog

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; HETASTARCH; LACTIC ACID; PYRUVIC ACID; TERLIPRESSIN; VASOPRESSIN DERIVATIVE;

ACIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; EXPERIMENTAL MODEL; FEMALE; HEART OUTPUT; HEMODYNAMICS; HEPATIC ARTERY; HYPERLACTATEMIA; LIVER BLOOD FLOW; LIVER ISCHEMIA; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; METABOLISM; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW; SWINE; SYSTEMIC VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; ENDOTOXEMIA; ENDOTOXINS; ESCHERICHIA COLI; FEMALE; GLUCOSE; HEMODYNAMIC PROCESSES; HYDROGEN-ION CONCENTRATION; LACTIC ACID; LIPOPOLYSACCHARIDES; LIVER CIRCULATION; LYSINE VASOPRESSIN; MALE; OXYGEN; OXYGEN CONSUMPTION; PYRUVIC ACID; SPLANCHNIC CIRCULATION; SWINE; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 13444252256     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000152253.45901.FB     Document Type: Article

References (47)

1. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-595
2. Hall S, Turcato S, Clapp L: Abnormal activation of K+ channels underlies relaxation to bacterial lipopolysaccharide in rat aorta. Biochem Biophys Res Commun 1996; 224: 184-190
3. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
4. Landry DW, Levin HR, Gallant EM, et al: Vasopressin presser hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25:1279-1282
5. Cronenwett JL, Baver-Neff BS, Grekin RJ, et al: The role of endorphins and Vasopressin in canine endotoxin shock. J Surg Res 1986; 41:609-619
6. Wilson MF, Brackett DJ, Archer LT, et al: Mechanisms of impaired cardiac function by Vasopressin. Ann Surg 1980; 191:494-500
7. Avontuur JA, Bruining HA, Ince C: Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 1995; 76:418-425
8. Oberti F, Veal N, Kaassis M, et al: Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats. J Hepatol 1998; 29: 103-111
9. Bernadich C, Bandi JC, Melin P, et al: Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology 1998; 27:351-356
10. Iwao T, Toyonaga A, Shigemori H, et al: Vasopressin plus oxygen vs Vasopressin alone in cirrhotic patients with portal-hypertensive gastropathy: Effects on gastric mucosal haemodynamics and oxygenation. J Gastroenterol Hepatol 1996; 11:216-222
11. Westphal M, Freise H, Kehrel BE, et al: Arginine Vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 2004; 32:194-200
12. Klinzing S, Simon M, Reinhart K, et al: High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003; 31:2646-2650
13. Dünser MW, Mayr AJ, Ulmer H, et al: Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation 2003; 107:2313-2319
14. Patel BM, Chittock DR, Russell JA, et al: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-582
15. Morelli A, Rocco M, Conti G, et al: Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 2004; 30:597-604
16. Asfar P, Pierrot M, Veal N, et al: Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 2003; 31:215-220
17. Sun Q, Dimopoulos G, Nguyen DN, et al: Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 2003; 168:481-486
18. Martikainen TJ, Tenhunen JJ, Uusaro A, et al: The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 2003; 97: 1756-1763
19. Oliver JA, Landry DW: Patient with a sudden drop in blood pressure. Crit Care Med 2003; 31:326-327
20. Traber DL: ATP and sepsis. Crit Care Med 1999; 27:865-866
21. Asfar P, Nalos M, Pittner A, et al: Adenosine triphosphate-magnesium dichloride during hyperdynamic porcine endotoxemia: Effects on hepatosplanchnic oxygen exchange and metabolism. Crit Care Med 2002; 30: 1826-1833
22. Vassilev D, Hauser B, Bracht H, et al: Systemic, pulmonary, and hepatosplanchnic effects of N-acetylcysteine during long-term porcine endotoxemia. Crit Care Med 2004; 32:525-532
23. Scharte M, Meyer J, Van Aken H, et al: Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001; 29: 1756-1760
24. Westphal M, Stubbe H, Sielenkämper W, et al: Terlipressin dose response in healthy and endotoxemic sheep: Impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003; 29:301-308
25. Murphey ED, Traber DL: Cardiopulmonary and splanchnic blood flow during 48 hours of continuous infusion of endotoxin in conscious pigs: A model of hyperdynamic shock. Shock 2000; 13:224-229
26. Lichtwarck-Aschoff M, Zeravik J, Pfeiffer UJ: Intrathoracic blood volume accurately reflects circulatory volume status in critically ill patients with mechanical ventilation. Intensive Care Med 1992; 18:142-147
27. Cooper KE, Kasting NW, Lederis K, et al: Evidence supporting a role for endogenous vasopressin in natural suppression of fever in the sheep. J Physiol 1979; 295:33-45
28. Cooper KE, Naylor AM, Veale WL: Evidence supporting a role for endogenous vasopressin in fever suppression in the rat. J Physiol 1987; 387:163-172
29. Mutlu GM, Factor P: Role of vasopressin in the management of septic shock. Intensive Care Med 2004; 30:1276-1291
30. Aiyar N, Nambi P, Crooke ST: Desensitization of vasopressin sensitive adenylate cyclase by vasopressin and phorbol esters. Cell Signal 1990; 2:153-160
31. Rudichenko VM, Beierwaltes WH: Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J Vasc Res 1995; 32: 100-105
32. Edwards RM, Trizna W, Kinter LB: Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 1989: 256:F274-F278
33. Albert M, Losser MR, Hayon D, et al: Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med 2004; 32: 1891-1898
34. Gundersen Y, Saetre T, Scholz T, et al: The NO donor sodium nitroprusside reverses the negative effects on hepatic arterial flow induced by endotoxin and the NO synthase inhibitor L-NAME. Eur Surg Res 1996; 28: 323-332
35. Ayuse T, Brienza N, Revelly JP, et al: Alternations in liver hemodynamics in an intact porcine model of endotoxin shock. Am J Physiol 1995; 268:H1106-H1114
36. Ayuse T, Brienza N, Revelly JP, et al: Role of nitric oxide in porcine liver circulation under normal and endotoxemic conditions. J Appl Physiol 1995; 78:1319-1329
37. Dahn MS, Mitchell RA, Lange MP, et al: Hepatic metabolic response to injury and sepsis. Surgery 1995; 117:520-530
38. Reinelt H, Radermacher P, Kiefer P, et al: Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 1999; 27: 325-331
39. Fencl V, Jabor A, Kazda A, et al: Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Dis 2000; 162:2246-2251
40. Dünser MW, Mayr AJ, Tür A, et al: Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors. Crit Care Med 2003; 31: 1394-1398
41. Mehta S, Javeshghani D, Datta P, et al: Porcine endotoxemic shock is associated with increased expired nitric oxide. Crit Care Med 1999; 27:385-393
42. Nüssler AK, Brückner UH, Vogt J, et al: Measuring end products of nitric oxide in vivo. Methods Enzymol 2002; 359:75-83
43. Mehta S, Magder S, Levy RD: The effects of changes in ventilation and cardiac output on expired nitric oxide. Chest 1997; 111: 1045-1049
44. Moreau R, Barriere E, Tazi KA, et al: Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis. Hepatology 2002; 36: 1070-1078
45. Giusti-Paiva A, De Castro M, Antunes-Rodrigues J, et al: Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release curing experimental septic shock. Crit Care Med 2002; 30: 1306-1310
46. Matejovic M, Krouzecky A, Martinkova V, et al: Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 2004; 21: 458-465
47. Malay MB, Ashton JL, Dahl K, et al: Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med 2004; 32:1327-1331